These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34390251)

  • 1. Re-calibrating pure risk integrating individual data from two-phase studies with external summary statistics.
    Zheng J; Zheng Y; Hsu L
    Biometrics; 2022 Dec; 78(4):1515-1529. PubMed ID: 34390251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Projection for Time-to-event Outcome Leveraging Summary Statistics With Source Individual-level Data.
    Zheng J; Zheng Y; Hsu L
    J Am Stat Assoc; 2022; 117(540):2043-2055. PubMed ID: 36687294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk projection for time-to-event outcome from population-based case-control studies leveraging summary statistics from the target population.
    Zheng J; Hsu L
    Lifetime Data Anal; 2024 Jul; 30(3):549-571. PubMed ID: 38805095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust risk prediction with biomarkers under two-phase stratified cohort design.
    Payne R; Yang M; Zheng Y; Jensen MK; Cai T
    Biometrics; 2016 Dec; 72(4):1037-1045. PubMed ID: 27037494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-phase approach to re-calibrating expensive computer simulation for sex-specific colorectal neoplasia development modeling.
    Vivas-Valencia C; Zhou Y; Sai A; Imperiale TF; Kong N
    BMC Med Inform Decis Mak; 2022 Sep; 22(1):244. PubMed ID: 36117168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kernel machine testing for risk prediction with stratified case cohort studies.
    Payne R; Neykov M; Jensen MK; Cai T
    Biometrics; 2016 Jun; 72(2):372-81. PubMed ID: 26692376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical Likelihood in Nonignorable Covariate-Missing Data Problems.
    Xie Y; Zhang B
    Int J Biostat; 2017 Apr; 13(1):. PubMed ID: 28441139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recalibration Methods for Improved Clinical Utility of Risk Scores.
    Mishra A; McClelland RL; Inoue LYT; Kerr KF
    Med Decis Making; 2022 May; 42(4):500-512. PubMed ID: 34605718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiparametric regression and risk prediction with competing risks data under missing cause of failure.
    Bakoyannis G; Zhang Y; Yiannoutsos CT
    Lifetime Data Anal; 2020 Oct; 26(4):659-684. PubMed ID: 31982977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical Bayes Estimation and Prediction Using Summary-Level Information From External Big Data Sources Adjusting for Violations of Transportability.
    Estes JP; Mukherjee B; Taylor JMG
    Stat Biosci; 2018 Dec; 10(3):568-586. PubMed ID: 31123532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
    PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonparametric covariate adjustment in estimating hazard ratios.
    Jiang H; Kulkarni PM; Wang Y; Mallinckrodt CH
    Pharm Stat; 2016; 15(1):46-53. PubMed ID: 26610282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recalibration of the SCORE risk chart for the Russian population.
    Jdanov DA; Deev AD; Jasilionis D; Shalnova SA; Shkolnikova MA; Shkolnikov VM
    Eur J Epidemiol; 2014 Sep; 29(9):621-8. PubMed ID: 25179794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical methods for analyzing right-censored length-biased data under cox model.
    Qin J; Shen Y
    Biometrics; 2010 Jun; 66(2):382-92. PubMed ID: 19522872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirical likelihood inference in randomized clinical trials.
    Zhang B
    Stat Methods Med Res; 2018 Dec; 27(12):3770-3784. PubMed ID: 28679341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of missing data due to drop-outs on estimators for rates of change in longitudinal studies: a simulation study.
    Touloumi G; Babiker AG; Pocock SJ; Darbyshire JH
    Stat Med; 2001 Dec; 20(24):3715-28. PubMed ID: 11782028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Information in the sample covariate distribution in prevalent cohorts.
    Cook RJ; Bergeron PJ
    Stat Med; 2011 May; 30(12):1397-409. PubMed ID: 21259303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight calibration to improve the efficiency of pure risk estimates from case-control samples nested in a cohort.
    Shin YE; Pfeiffer RM; Graubard BI; Gail MH
    Biometrics; 2020 Dec; 76(4):1087-1097. PubMed ID: 31863593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.